Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Impact of Semaglutide on CD34+ EPC and Fat Derived MSC
- First Posted Date
- 2019-10-15
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Sabyasachi Sen
- Target Recruit Count
- 38
- Registration Number
- NCT04126603
- Locations
- 🇺🇸
The GW Medical Faculty Associates, Washington, District of Columbia, United States
🇺🇸Washington VA Medical Center, Washington, District of Columbia, United States
Effect on HIV Medications on EPC Cells
Completed
- Conditions
- AIDS
- Interventions
- First Posted Date
- 2018-12-20
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Sabyasachi Sen
- Target Recruit Count
- 22
- Registration Number
- NCT03782142
- Locations
- 🇺🇸
The GW Medical Faculty Associates, Washington, District of Columbia, United States
Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus
Phase 4
Terminated
- Conditions
- Cardiovascular DiseasesDiabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2018-09-06
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Sabyasachi Sen
- Target Recruit Count
- 15
- Registration Number
- NCT03660683
- Locations
- 🇺🇸
The GW Medical Faculty Associates, Washington, District of Columbia, United States
News
No news found